Alvotech
ALVONasdaqHealthcare · Biological Products, (No Diagnostic Substances) · N4 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Clinical trials
ClinicalTrials.gov · ongoing · next readout first- Phase 3Recruitingreadout ~2027-07Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema
- Phase 1Not Yet Recruitingreadout ~2027-10A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Interventional studies led by this company. “Readout” is the trial's primary-completion date — an estimate the sponsor reports, not a guarantee.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Aztiq Pharma Partners S.A R.L.Activist (13D)Mar 12, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.5M | 6.0 | +7.0% |
| Apr 30, 2026 | 2.4M | 5.8 | -12.1% |
| Apr 15, 2026 | 2.7M | 7.6 | -10.0% |
| Mar 31, 2026 | 3.0M | 4.4 | +22.1% |
| Mar 13, 2026 | 2.5M | 3.7 | -17.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KMay 11, 2026
- 6-KFORM 6-KMay 4, 2026
- 20-FMar 31, 2026
- 6-KFORM 6-KMar 19, 2026
- SCHEDULE 13D/AMar 12, 2026
- 6-KFORM 6-KFeb 27, 2026
- 6-KFORM 6-KFeb 5, 2026
- 6-KFORM 6-KFeb 2, 2026
- 6-KFORM 6-KJan 29, 2026
- 6-KFORM 6-KJan 7, 2026
- 6-KFORM 6-KJan 7, 2026
- 6-KFORM 6-KJan 6, 2026
- 6-KFORM 6-KJan 2, 2026
- 6-KFORM 6-KDec 23, 2025
- 6-KFORM 6-KDec 19, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.